Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Obstetrics · Congenital Cytomegalovirus

Congenital CMV during Pregnancy: Risks, Diagnosis, and Management

At a Glance

Congenital CMV risk during pregnancy depends on whether it is a primary infection or a reactivation. Doctors use IgG avidity tests to date the infection, amniocentesis to check the baby, and high-dose valacyclovir to help reduce the risk of transmission.

Finding out you have a Cytomegalovirus (CMV) infection during pregnancy can be frightening, but understanding your diagnosis and the available interventions can help you and your medical team make the best decisions for your family. While CMV is very common, the timing and type of infection determine the level of risk to your baby.

Understanding Your Infection Type

The risk of passing the virus to your baby—called vertical transmission—depends heavily on whether this is your first time having CMV.

  • Primary Infection: If this is the first time you have ever had CMV, the risk of transmission to the baby is roughly 30% to 50% [1]. Infections that happen in the first trimester or just before conception carry the highest risk for more severe symptoms in the baby [2].
  • Non-Primary Infection: This happens if a previous “sleeping” CMV infection wakes up (reactivation) or if you catch a different strain of the virus (reinfection) [3]. The risk of passing the virus to the baby is much lower in these cases, though it is not zero [4].

Dating the Infection: The “Avidity” Test

Doctors use specific blood tests to figure out when you were infected.

  1. IgG and IgM Antibodies: Your body produces IgM first, followed by IgG. However, IgM can stay positive for months, so it isn’t always a perfect timer [5].
  2. IgG Avidity: This is the most helpful tool for dating. It measures how “sticky” your antibodies are. Low avidity means the infection is recent (usually within the last 3 months) [6]. High avidity means the infection happened at least 3 to 6 months ago, which often means the baby is at much lower risk if you are already several months into your pregnancy [7].

Practical Prevention Tips

Because CMV is often spread by young children (who shed the virus in their saliva and urine for months), pregnant women who are CMV-negative can reduce their risk of a new infection by:

  • Washing hands frequently, especially after changing diapers or wiping noses.
  • Avoiding sharing food, utensils, or cups with toddlers.
  • Avoiding kissing young children on the mouth or cheek (kissing on the forehead or head is safer) [8].

Monitoring the Baby: Ultrasound and Amniocentesis

If a recent infection is confirmed, your care team will monitor the baby closely.

Ultrasound Findings

Doctors look for specific markers on an ultrasound that might suggest the virus is affecting the baby, such as:

  • Hyperechoic bowel: The baby’s intestines look brighter than usual [9].
  • Brain changes: These include a hyperechoic thalamus (bright spots in a specific brain region), fluid-filled spaces (cysts), or small head size (microcephaly) [10][11].

Amniocentesis: The Gold Standard

To know for sure if the baby has the virus, an amniocentesis is performed. A small amount of amniotic fluid is tested using a PCR test to look for viral DNA [12].

  • Timing is critical: For the most accurate result, the procedure is usually done at or after 21 weeks of pregnancy and at least 6 to 8 weeks after the mother was first infected [13][14].

Preventing Transmission: Valacyclovir

A major development in prenatal care is the use of high-dose valacyclovir (an antiviral medication) to reduce the risk of the virus passing to the baby.

  • The Goal: Studies show that taking 8 grams per day (usually 2g taken four times daily) starting in the first trimester can significantly lower the chance of the baby catching the virus specifically following a primary maternal infection [15][16].
  • Safety: While generally safe, this high dose requires you to stay very well hydrated and have regular blood tests to check your serum creatinine (a measure of kidney function) [17][18].

While these steps can feel clinical and complex, they are designed to give you the clearest picture possible and offer active ways to protect your baby’s health. Once the baby is born, they will be tested and monitored according to the guidelines in our Newborn Monitoring section.

Common questions in this guide

How do doctors know when I caught CMV?
Doctors use a specific blood test called IgG avidity to measure how recent the infection is. Low avidity means the infection likely happened within the last three months, while high avidity indicates it happened longer ago.
How can I prevent catching CMV while pregnant?
Since CMV is frequently spread by young children, you can reduce your risk by washing your hands often after changing diapers or wiping noses. You should also avoid sharing food or utensils with toddlers and avoid kissing them on the mouth.
Can medication prevent my baby from getting CMV?
Yes, studies show that taking a high dose of the antiviral medication valacyclovir, typically starting in the first trimester, can significantly reduce the risk of passing a primary CMV infection to your baby.
When is the best time to have an amniocentesis for CMV?
For the most accurate PCR test results, an amniocentesis is usually performed at or after 21 weeks of pregnancy, and at least 6 to 8 weeks after you were first infected with the virus.
What ultrasound signs suggest a baby might have CMV?
During an ultrasound, doctors look for markers such as a brighter-than-normal bowel (hyperechoic bowel), fluid-filled spaces in the brain, bright spots in specific brain regions, or a smaller head size.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my blood work, what is the estimated date of my infection, and how does that affect the risk to the baby?
  2. 2.Given the timing of my infection, what are the pros and cons of starting high-dose valacyclovir right now?
  3. 3.How often will we perform ultrasounds, and should we also schedule a fetal MRI to look more closely at the baby's brain?
  4. 4.When is the best time for me to have an amniocentesis for the most accurate results?
  5. 5.If I start valacyclovir, how will you monitor my kidney function during treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Diagnosis and antenatal management of congenital cytomegalovirus infection.

    , Hughes BL, Gyamfi-Bannerman C

    American journal of obstetrics and gynecology 2016; (214(6)):B5-B11.

    PMID: 26902990
  2. 2

    Sequelae of Congenital Cytomegalovirus Following Maternal Primary Infections Are Limited to Those Acquired in the First Trimester of Pregnancy.

    Faure-Bardon V, Magny JF, Parodi M, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019; (69(9)):1526-1532 doi:10.1093/cid/ciy1128.

    PMID: 30596974
  3. 3

    Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring.

    Demmler-Harrison GJ, Miller JA,

    PloS one 2020; (15(10)):e0240172 doi:10.1371/journal.pone.0240172.

    PMID: 33035237
  4. 4

    Fetal Cytomegalovirus Infection in the Absence of Maternal Cytomegalovirus-IgM Seropositivity.

    Erenel H, Tuna G, Alpay V, Polat İ

    Reproductive sciences (Thousand Oaks, Calif.) 2024; (31(6)):1533-1540 doi:10.1007/s43032-024-01487-x.

    PMID: 38388923
  5. 5

    Deciphering Positive Cytomegalovirus Immunoglobulin M Test Results in Immunocompetent Adults Hospitalized With Illness Suspicious for Acute Cytomegalovirus Infection: A Multihospital Study.

    Samuel S, Thomas S, Asleson L, et al.

    Open forum infectious diseases 2025; (12(3)):ofaf144 doi:10.1093/ofid/ofaf144.

    PMID: 40134634
  6. 6

    Cytomegalovirus infection in pregnancy - An update.

    Navti OB, Al-Belushi M, Konje JC,

    European journal of obstetrics, gynecology, and reproductive biology 2021; (258()):216-222 doi:10.1016/j.ejogrb.2020.12.006.

    PMID: 33454510
  7. 7

    Potential Biomarkers for Predicting Congenital Cytomegalovirus Infection.

    Tanimura K, Yamada H

    International journal of molecular sciences 2018; (19(12)) doi:10.3390/ijms19123760.

    PMID: 30486359
  8. 8

    CMV-induced Hearing Loss.

    Singh S, Maheshwari A, Boppana S

    Newborn (Clarksville, Md.) 2023; (2(4)):249-262 doi:10.5005/jp-journals-11002-0081.

    PMID: 38348106
  9. 9

    Pathophysiology of Hyperechogenic Bowel in Congenitally Human Cytomegalovirus Infected Fetuses.

    Gabrielli L, Bonasoni MP, Chiereghin A, et al.

    Microorganisms 2020; (8(5)) doi:10.3390/microorganisms8050779.

    PMID: 32455864
  10. 10

    Ultrasound features of congenital cytomegalovirus infection in the first trimester: A case report.

    Chen XL, Zhang LQ, Bai LL

    World journal of clinical cases 2025; (13(5)):97629 doi:10.12998/wjcc.v13.i5.97629.

    PMID: 39959771
  11. 11

    Congenital cytomegalovirus infection with brainstem hemorrhage and polymicrogyria: Necropsic and histopathological findings.

    Arredondo Montero J, Bronte Anaut M, Caballero Martínez MC, et al.

    Congenital anomalies 2022; (62(6)):248-253 doi:10.1111/cga.12488.

    PMID: 35941838
  12. 12

    Associations Between Fetal Symptoms During Pregnancy and Neonatal Clinical Complications with Cytomegalovirus Infection.

    Bartek V, Csire M, Kiss G, et al.

    Children (Basel, Switzerland) 2025; (12(12)) doi:10.3390/children12121690.

    PMID: 41462830
  13. 13

    Amniocentesis for prenatal diagnosis of cytomegalovirus infection: challenging the 21 weeks' threshold.

    Enders M, Daiminger A, Exler S, Enders G

    Prenatal diagnosis 2017; (37(9)):940-942 doi:10.1002/pd.5107.

    PMID: 28677115
  14. 14

    Counseling in fetal medicine: Congenital cytomegalovirus infection.

    D'Alberti E, Rizzo G, Khalil A, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2024; (295()):8-17 doi:10.1016/j.ejogrb.2024.01.037.

    PMID: 38310675
  15. 15

    [Secondary Prevention of Fetal Cytomegalovirus Infection Through Valacyclovir Administration in Maternal Primary Infections During the Periconceptional Period and First Trimester of Pregnancy].

    Chatzakis C, Bourgon N, Leruez-Ville M, Ville Y

    Gynecologie, obstetrique, fertilite & senologie 2025; (53(7-8)):341-348 doi:10.1016/j.gofs.2025.03.010.

    PMID: 40185476
  16. 16

    The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection.

    Chatzakis C, Bourgon N, Fourgeaud J, et al.

    Best practice & research. Clinical obstetrics & gynaecology 2025; (103()):102679 doi:10.1016/j.bpobgyn.2025.102679.

    PMID: 41175678
  17. 17

    Renal toxicity of high-dosage valacyclovir for secondary prevention of congenital cytomegalovirus infection: a dose regimen-related issue.

    Ville Y, Leruez-Ville M

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2021; (58(4)):637-638 doi:10.1002/uog.24753.

    PMID: 34468055
  18. 18

    Estimating Risks of Central Nervous System Disturbance Associated with Medications for Herpes Zoster: Findings from a Regional Population-Based Cohort Study Using the Shizuoka Kokuho Database.

    Hagiwara R, Nakatani E, Kaneda H, et al.

    Drugs - real world outcomes 2025; (12(3)):399-410 doi:10.1007/s40801-025-00500-2.

    PMID: 40522612

This page is for informational purposes only and does not replace professional medical advice. Always consult your obstetrician or maternal-fetal medicine specialist about CMV testing, monitoring, and treatment during your pregnancy.

Get notified when new evidence is published on Cytomegalovirus Infection.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.